# Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

> **NCT07743996** · — · RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 100 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07743996
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07743996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07743996, "Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07743996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*